0 mg Prednisone ( DrugBank: Prednisone )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
44	Wegener granulomatosis	2

44. Wegener granulomatosis

---

Clinical trials : 92 /  Drugs : 106 - (DrugBank : 27) / Drug target genes : 22 - Drug target pathways : 78

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01933724 (ClinicalTrials.gov)	February 17, 2014	28/8/2013	The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach	The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach	Granulomatosis With Polyangiitis;Wegener Granulomatosis;Vasculitis	Drug: 5 mg prednisone;Drug: 0 mg prednisone	University of South Florida	National Institutes of Health (NIH);National Heart, Lung, and Blood Institute (NHLBI);National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS);Office of Rare Diseases (ORD);National Center for Advancing Translational Science (NCATS);Rare Diseases Clinical Research Network	Active, not recruiting	18 Years	N/A	All	12	Phase 3	United States
2	NCT01940094 (ClinicalTrials.gov)	February 2014	6/9/2013	The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach	The Assessment of Prednisone In Remission Trial (TAPIR) - Centers of Excellence Approach	Granulomatosis With Polyangiitis	Drug: 5 mg Prednisone;Drug: 0 mg Prednisone	University of Pennsylvania	National Heart, Lung, and Blood Institute (NHLBI);National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS);Office of Rare Diseases (ORD);National Center for Advancing Translational Science (NCATS);Rare Diseases Clinical Research Network	Recruiting	18 Years	N/A	All	159	Phase 3	United States;Canada